0001493152-23-010884.txt : 20230404
0001493152-23-010884.hdr.sgml : 20230404
20230404195244
ACCESSION NUMBER: 0001493152-23-010884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230403
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAHAREK JOHN P.
CENTRAL INDEX KEY: 0001632091
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 23800627
MAIL ADDRESS:
STREET 1: 12264 EL CAMINO REAL
STREET 2: SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER NAME:
FORMER CONFORMED NAME: Saharek John
DATE OF NAME CHANGE: 20150128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW HEALTH, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
BUSINESS PHONE: 615.733.4731
MAIL ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
FORMER COMPANY:
FORMER CONFORMED NAME: Bywater Resources, Inc
DATE OF NAME CHANGE: 20060421
4
1
ownership.xml
X0407
4
2023-04-03
0
0001360214
HARROW HEALTH, INC.
HROW
0001632091
SAHAREK JOHN P.
C/O HARROW HEALTH, INC.
102 WOODMONT BLVD, SUITE 610
NASHVILLE
TN
37205
0
1
0
0
Chief Commercial Officer
0
Restricted Stock Unit
2023-04-03
4
A
0
277200
0
A
2028-04-03
Common Stock
277200
277200
D
Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a two-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $25 (causing the vesting of 39,600 PSU shares), $35 (causing the vesting of 59,400 PSU shares), $45 (causing the vesting of 79,200 PSU shares), $50 (causing the vesting of 99,000 PSU shares).
/s/ John P. Saharek
2023-04-04